Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/8818
DC FieldValueLanguage
dc.contributor.authorRistevska, Nevenaen_US
dc.contributor.authorStojanoski, Sinisaen_US
dc.contributor.authorPop Gjorcheva, Danielaen_US
dc.date.accessioned2020-08-24T11:07:28Z-
dc.date.available2020-08-24T11:07:28Z-
dc.date.issued2015-03-
dc.identifier.issn1318-2099-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/8818-
dc.description.abstractHürthle cell neoplasms could be benign (Hürthle cell adenoma) or malignant (Hürthle cell carcinoma). Hürthle cell carcinoma is a rare tumour, representing 5% of all differentiated thyroid carcinomas. The cytological evaluation of Hürthle cell neoplasms by fine needle aspiration biopsy (FNAB) is complicated because of the presence of Hürthle cells in both Hürthle cell adenoma and Hürthle cell carcinoma. Thus, the preoperative distinction between these two entities is very difficult and possible only with pathohistological findings of the removed tumour.en_US
dc.language.isoenen_US
dc.publisherWalter de Gruyter GmbHen_US
dc.relation.ispartofRadiology and Oncologyen_US
dc.titleAppearance of Hürthle cell carcinoma soon after surgical extirpation of Hürthle cell adenoma and follicular adenoma of the thyroid glanden_US
dc.typeArticleen_US
dc.identifier.doi10.2478/raon-2014-0047-
dc.identifier.urlhttps://content.sciendo.com/view/journals/raon/49/1/article-p26.xml-
dc.identifier.urlhttps://www.degruyter.com/view/j/raon.2015.49.issue-1/raon-2014-0047/raon-2014-0047.pdf-
dc.identifier.volume49-
dc.identifier.issue1-
item.grantfulltextnone-
item.fulltextNo Fulltext-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Page view(s)

108
checked on Jul 24, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.